argenx Past Earnings Performance

Past criteria checks 0/6

argenx's earnings have been declining at an average annual rate of -15.8%, while the Biotechs industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 54.6% per year.

Key information

-15.8%

Earnings growth rate

-9.7%

EPS growth rate

Biotechs Industry Growth-3.6%
Revenue growth rate54.6%
Return on equity-8.0%
Net Margin-22.6%
Next Earnings Update25 Jul 2024

Recent past performance updates

Recent updates

argenx SE's (EBR:ARGX) CEO Looks Like They Deserve Their Pay Packet

May 01
argenx SE's (EBR:ARGX) CEO Looks Like They Deserve Their Pay Packet

Investors Appear Satisfied With argenx SE's (EBR:ARGX) Prospects

Apr 11
Investors Appear Satisfied With argenx SE's (EBR:ARGX) Prospects

Analyst Estimates: Here's What Brokers Think Of argenx SE (EBR:ARGX) After Its Yearly Report

Mar 24
Analyst Estimates: Here's What Brokers Think Of argenx SE (EBR:ARGX) After Its Yearly Report

Analysts Have Made A Financial Statement On argenx SE's (EBR:ARGX) Full-Year Report

Mar 05
Analysts Have Made A Financial Statement On argenx SE's (EBR:ARGX) Full-Year Report

argenx SE (EBR:ARGX) Shares Could Be 24% Below Their Intrinsic Value Estimate

Feb 23
argenx SE (EBR:ARGX) Shares Could Be 24% Below Their Intrinsic Value Estimate

Getting In Cheap On argenx SE (EBR:ARGX) Is Unlikely

Dec 18
Getting In Cheap On argenx SE (EBR:ARGX) Is Unlikely

Broker Revenue Forecasts For argenx SE (EBR:ARGX) Are Surging Higher

Jul 28
Broker Revenue Forecasts For argenx SE (EBR:ARGX) Are Surging Higher

An Intrinsic Calculation For argenx SE (EBR:ARGX) Suggests It's 31% Undervalued

Jul 17
An Intrinsic Calculation For argenx SE (EBR:ARGX) Suggests It's 31% Undervalued

Revenues Tell The Story For argenx SE (EBR:ARGX)

Jun 20
Revenues Tell The Story For argenx SE (EBR:ARGX)

argenx (EBR:ARGX) Is Using Debt Safely

May 08
argenx (EBR:ARGX) Is Using Debt Safely

We Think argenx (EBR:ARGX) Can Afford To Drive Business Growth

Apr 20
We Think argenx (EBR:ARGX) Can Afford To Drive Business Growth

Does argenx (EBR:ARGX) Have A Healthy Balance Sheet?

Dec 27
Does argenx (EBR:ARGX) Have A Healthy Balance Sheet?

We're Not Very Worried About argenx's (EBR:ARGX) Cash Burn Rate

Oct 08
We're Not Very Worried About argenx's (EBR:ARGX) Cash Burn Rate

Revenue & Expenses Breakdown

How argenx makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTBR:ARGX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241,451-3287990
31 Dec 231,269-2957120
30 Sep 231,029-2346380
30 Jun 23835-3975550
31 Mar 23639-5115200
31 Dec 22441-7104720
30 Sep 22286-9094340
30 Jun 22146-9074070
31 Mar 22381-5953520
31 Dec 21528-4083080
30 Sep 21510-3732700
30 Jun 21526-3192330
31 Mar 21206-5732040
31 Dec 2062-6081720
30 Sep 2075-5351440
30 Jun 2070-3591100
31 Mar 2073-275860
31 Dec 1993-181720
30 Sep 1972-109560
30 Jun 1968-104490
31 Mar 1970-47370
31 Dec 1833-76310
30 Sep 1841-56270
30 Jun 1844-47220
31 Mar 1850-46180
31 Dec 1749-34150
30 Sep 1742-30110
30 Jun 1739-25100
31 Mar 1723-29100
31 Dec 1618-2270
30 Sep 1617-2070
30 Jun 1614-1760
31 Mar 1612-1760
31 Dec 1511-1750
30 Sep 1510-1650
30 Jun 159-1450
31 Mar 157-1240
31 Dec 147-1240
30 Sep 146-1040
30 Jun 147-830
31 Mar 147-930
31 Dec 137-830

Quality Earnings: ARGX is currently unprofitable.

Growing Profit Margin: ARGX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ARGX is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.

Accelerating Growth: Unable to compare ARGX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ARGX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (3%).


Return on Equity

High ROE: ARGX has a negative Return on Equity (-8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.